The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the seniors' pharmacare program in Nova Scotia, Canada

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  Sanyal, Chiranjeev ^a   Graham, Stephen D ^b   Cooke, Charmaine ^b   Sketris, Ingrid ^a,b   Frail, Dawn M ^c   Flowerdew, Gordon ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Nova Scotia Department of Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROPAMIDE; DETERMIR; GLIMEPIRIDE; GLUCONORM; GLUCOSE; HYPERGLYCEMIC AGENT; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; LEVIMER; METFORMIN PLUS ROSIGLITAZONE; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; ANTIDIABETIC AGENT;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CANADA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TEST STRIP; BLOOD; ECONOMICS; ELDERLY CARE; HEALTH SERVICES RESEARCH; INSTRUMENTATION; INSURANCE; STATISTICS;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE SELF-MONITORING; CANADA; DIABETES MELLITUS; FEMALE; HEALTH SERVICES FOR THE AGED; HEALTH SERVICES RESEARCH; HUMANS; HYPOGLYCEMIC AGENTS; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; MALE; NOVA SCOTIA; PRACTICE GUIDELINES AS TOPIC; REAGENT STRIPS; RETROSPECTIVE STUDIES;

EID: 44949102520     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-111     Document Type: Article

References (45)

1. Consensus statement on self-monitoring in diabetes: Institute of health economics, Alberta, Canada, November 14-16, 2006. International Journal of Technology Assessment in Health Care 2007 23 01 146 151 17405242
2. Prevalence of diabetes in Canada by province, and sex for persons 20 years and older (excluding New Brunswick, Newfoundland, Nunavut, Northwest Territories). http://secure.cihi.ca/cihiweb/en/ pirc_indicators_7d_Province_sex_e.html Accessed on July 19, 2007
3. Diabetes in Nova Scotia. A ten year perspective by: Diabetes care program of Nova Scotia. http://www.diabetescareprogram.ns.ca/statistics/diab.pdf Accessed on July 19, 2007
4. The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Arto Ohinmaa Philip Jacobs Scot Simpson Jeffrey A Johnson, Can J Diabetes 2004 28 116 123
5. Questions and Answers about Pharmacare Benefits and Reimbursement. http://www.gov.ns.ca/health/Pharmacare/benefitsfaq.asp Accessed on January 8, 2008
6. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. P Gaede P Vedel N Larsen GV Jensen HH Parving O Pedersen, N Engl J Med 2003 348 383 393 10.1056/NEJMoa021778 12556541
7. Effect of a multifactorial intervention on mortality in type 2 diabetes. P Goede H Lund-Andersen HH Parving O Pedersen, N Engl J Med 2008 358 580 591 10.1056/NEJMoa0706245 18256393
8. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. CD Saudek RL Derr RR Kalyani, JAMA 2006 295 1688 1697 10.1001/jama.295.14.1688 16609091
9. National standards for diabetes self-management education. C Mensing J Boucher M Cypress K Weinger K Mulcahy P Barta G Hosey W Kopher A Lasichak B Lamb M Mangan J Norman J Tanja L Yauk K Wisdom C Adams, Diabetes Care 2006 29 Suppl 1 S78 85 16373939
10. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: A qualitative study of patients' perspectives. E Peel O Parry M Douglas J Lawton, Br J Gen Pract 2004 54 183 188 15006123
11. Glucose self-monitoring in primary care: A survey of current practice. D Stewart D McCaig A Davie L Juroszek L Blackwood N Findlay S McCarthy, J Clin Pharm Ther 2004 29 273 277 10.1111/j.1365-2710.2004.00555.x 15153090
12. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. JA Johnson SL Pohar K Secnik N Yurgin Z Hirji, BMC Health Serv Res 2006 6 159 17164006 10.1186/1472-6963-6-159
13. American diabetes association. Checking your blood glucose. http://www.diabetes.org/type-2-diabetes/blood-glucose-checks.jsp Accessed on July 19, 2007
14. Alternate site blood glucose testing: Do patients prefer it? KL Tieszen JP New, Diabet Med 2003 20 325 328 10.1046/j.1464-5491.2003.00927.x 12675648
15. Self monitoring of blood glucose in type 2 diabetes: Longitudinal qualitative study of patients' perspectives. E Peel M Douglas J Lawton, BMJ 2007 335 493 17761996 10.1136/bmj.39302.444572.DE
16. Frequency of blood glucose monitoring in relation to glycaemic control: Observational study with diabetes database. JM Evans RW Newton DA Ruta TM MacDonald RJ Stevenson AD Morris, BMJ 1999 319 83 86 10398627
17. Self-monitoring of blood glucose; frequency, determinants and self-adjustment of treatment in an adult Swedish diabetic population utilisation and determinants of SMBG. Katarina Hjelm Per Nyberg Jan Apelqvist, Practical Diabetes Int 2001 18 5 157 163 10.1002/pdi.203
18. Self-monitoring of blood glucose: Language and financial barriers in a managed care population with diabetes. AJ Karter A Ferrara JA Darbinian LM Ackerson JV Selby, Diabetes Care 2000 23 477 483 10.2337/diacare.23.4.477 10857938
19. Out-of-pocket costs and diabetes preventive services: The translating research into action for diabetes (TRIAD) study. AJ Karter MR Stevens WH Herman S Ettner DG Marrero MM Safford MM Engelgau JD Curb AF Brown Translating Research Into Action for Diabetes Study Group, Diabetes Care 2003 26 2294 2299 10.2337/diacare.26.8.2294 12882851
20. Self-monitoring of blood glucose by adults with diabetes in the United States population. MI Harris CC Cowie LJ Howie, Diabetes Care 1993 16 1116 1123 10.2337/diacare.16.8.1116 8375241
21. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. SB Soumerai C Mah F Zhang A Adams M Barton V Fajtova D Ross-Degnan, Arch Intern Med 2004 164 645 652 10.1001/archinte.164.6.645 15037493
22. Self-monitoring in type 2 diabetes: A randomized trial of reimbursement policy. JA Johnson SR Majumdar SL Bowker EL Toth A Edwards, Diabet Med 2006 23 1247 1251 10.1111/j.1464-5491.2006.01973.x 17054603
23. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente diabetes registry. AJ Karter LM Ackerson JA Darbinian RB D'Agostino Jr A Ferrara J Liu JV Selby, Am J Med 2001 111 1 9 10.1016/S0002-9343(01)00742-2 11448654
24. Self-monitoring in type 2 diabetes mellitus: A meta-analysis. S Coster MC Gulliford PT Seed JK Powrie R Swaminathan, Diabet Med 2000 17 755 761 10.1046/j.1464-5491.2000.00390.x 11131099
25. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. A Faas FG Schellevis JT Van Eijk, Diabetes Care 1997 20 1482 1486 10.2337/diacare.20.9.1482 9283802
26. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. MI Harris National Health and Nutrition Examination Survey (NHANES III), Diabetes Care 2001 24 979 982 10.2337/diacare.24.6.979 11375356
27. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Can J Diabetes 2003 27 Suppl 2 S1 152
28. Monitoring blood glucose control in diabetes mellitus: A systematic review. S Coster MC Gulliford PT Seed JK Powrie R Swaminathan, Health Technol Assess 2000 4 i iv 1-93 10944740
29. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open parallel group randomised trial. A Farmer A Wade E Goyder P Yudkin D French A Craven R Holman AL Kinmonth A Neil, BMJ 2007 335 132 17591623 10.1136/bmj.39247.447431.BE
30. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. LM Welschen E Bloemendal G Nijpels JM Dekker RJ Heine WA Stalman LM Bouter, Cochrane Database Syst Rev 2005 2 CD005060 15846742
31. Self-monitoring of glucose levels for people with type 2 diabetes. V Holmes P Griffiths, Br J Community Nurs 2002 7 41 46 11823730
32. Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. A Tengblad E Grodzinsky K Lindstrom S Molstad L Borgquist CJ Ostgren, Scand J Prim Health Care 2007 25 140 146 10.1080/02813430701267413 17846931
33. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle diabetes study. WA Davis DG Bruce TM Davis, Diabetes Care 2006 29 1764 1770 10.2337/dc06-0268 16873777
34. Point: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: The sanguine approach. E Ipp RL Aquino P Christenson, Diabetes Care 2005 28 1528 1530 10.2337/diacare.28.6.1528 15920087
35. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: A waste of money. MB Davidson, Diabetes Care 2005 28 1531 1533 10.2337/diacare.28.6.1531 15920088
36. About the ATC/DDD system. http://www.whocc.no/atcddd/ Accessed on July 19, 2007
37. OPINIONS database. http://pans.ns.ca/default.asp?id=190&sfield= content.id&search=6&mn=5.23 Accessed on January 17, 2008
38. Population health research unit. http://www.phru.dal.ca Accessed on July 19, 2007
39. SAS institute, inc. http://www.sas.com/ Accessed on July 19, 2007
40. Diabetes care program of Nova Scotia. http://www.diabetescareprogram.ns. ca Accessed on January 16, 2008
41. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: A pilot study. BW Bode TM Gross KR Thornton JJ Mastrototaro, Diabetes Res Clin Pract 1999 46 183 190 10.1016/S0168-8227(99) 00113-8 10624783
42. The Nova Scotia formulary - January 2007. http://www.gov.ns.ca/health/ Pharmacare/formulary.pdf Accessed on June 02, 2008
43. The cost of diabetes testing strips in Saskatchewan, 1996: A retrospective database analysis. CG Mitchell SH Simpson JA Johnson, Canadian Journal of Diabetes 2003 27 2 149 153
44. Tests of glycemia in diabetes. DE Goldstein RR Little RA Lorenz JI Malone DM Nathan CM Peterson American Diabetes Association, Diabetes Care 2003 26 Suppl 1 S106 8 12502632
45. Cost-effectiveness of self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin. K Neeser K Erny-Albrecht C Weber, Diabetes Care 2006 29 480; author reply 480-1 10.2337/diacare.29.02.06.dc05-1857 16482704